JD Supra7d
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Business Wire10d
DOJ Asks Court to Dismiss FTC-Xlear Lawsuit
DOJ ASKS COURT TO DISMISS FTC-XLEAR LAWSUIT; Calls into Question FTC’s Authority to Require Clinical Studies for Non-Pharmaceutical Health Products ...
Business Wire13d
Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
“The results of these clinical studies further illustrate our commitment to ... 5 Evaluating the Variability in Effective Protection Against Ultraviolet A (UVA) Radiation-Induced Pigmentation Provided ...